CDK5 and Alzheimer disease: Both GSK-3β and CDK5 have the capacity to phosphorylate tau at multiple sites associated with AD, including Ser202, Thr212, Ser214, Ser404, Ser217, Thr205, Thr231, Ser235, and Ser396 [145,146,147].